Why the study?
Is point-of-care screening for ideal cardiovascular health feasible in a pediatric specialty clinic setting?
Cross-Sectional (n=91)
Is point-of-care screening for ideal cardiovascular health feasible in a pediatric specialty clinic setting?
Point-of-care screening for ideal cardiovascular health is feasible in a pediatric specialty clinic and identifies risk factor clustering.
Answers are grounded in this paper and cite their sources.
Point-of-care non-HDL-C screening may flag clustered risks in pediatric patients; hypothesis-generating from cross-sectional data, needs prospective validation.
The feasibility of "point-of-care" screening for ideal cardiovascular health was explored in a pediatric specialty clinic setting. Children and adolescents aged 9-18 years (n=91) with treated and stabilized diseases were recruited at a pediatric endocrinology clinic. A table-top device was used to assay fingerstick samples for non-HDL cholesterol (non-HDL-C), which was used to divide participants into two groups based on the non-HDL-C threshold for comparison of the remaining metrics between groups. A significant number of children had low scores, and score frequency distribution was similar to larger retrospective studies, with few participants achieving none or all of the health metrics. Healthy diet was the metric least often achieved. Those with a non-HDL-C above the ideal threshold of 3.1 mmol/L (120 mg/dl) had a higher BMI percentile (p<0.01) and diastolic blood pressure percentile (p<0.05). We conclude that pediatric risk factor screening and scoring can be performed in a specialty clinic with meaningful cardiovascular health scores for patients and providers. Association of abnormal "point-of care" non-HDL-C levels with elevated BMI and blood pressure supports evidence for risk factor clustering and use of the ideal health construct in pediatric clinic settings.
No takes yet. Share an insight, caveat, or question.
Blackett et al. (2018) conducted a cross-sectional in treated and stabilized diseases (n=91). non-HDL-C > 3.1 mmol/L vs. non-HDL-C ≤ 3.1 mmol/L was evaluated on BMI percentile and diastolic blood pressure percentile (p=<0.01 and <0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: